Home/Filings/4/0001209191-22-013754
4//SEC Filing

Cancelmi Daniel J 4

Accession 0001209191-22-013754

CIK 0000070318other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 6:39 PM ET

Size

21.7 KB

Accession

0001209191-22-013754

Insider Transaction Report

Form 4
Period: 2022-02-24
Cancelmi Daniel J
Principal Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-24+8,672370,672 total
  • Tax Payment

    Common Stock

    2022-02-24$81.20/sh3,432$278,678367,240 total
  • Exercise/Conversion

    Common Stock

    2022-02-25+14,988382,228 total
  • Tax Payment

    Common Stock

    2022-02-25$85.71/sh5,898$505,518376,330 total
  • Exercise/Conversion

    Common Stock

    2022-02-25+9,044385,374 total
  • Tax Payment

    Common Stock

    2022-02-25$85.71/sh3,559$305,042381,815 total
  • Exercise/Conversion

    2021 February Restricted Stock Units

    2022-02-248,67217,346 total
    Common Stock (8,672 underlying)
  • Exercise/Conversion

    2020 February Restricted Stock Units

    2022-02-2514,98814,989 total
    Common Stock (14,988 underlying)
  • Exercise/Conversion

    2019 February Restricted Stock Units

    2022-02-259,0440 total
    Common Stock (9,044 underlying)
Footnotes (6)
  • [F1]As previously reported, on February 24, 2021, the reporting person received a grant of 26,018 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 24, 2022, resulting in the vesting and settlement of 8,672 shares of common stock, as shown in Table I. The remaining 17,346 restricted stock units are shown in Table II, of which 8,673 are scheduled to vest on each of February 24, 2023, and February 24, 2024.
  • [F2]Restricted stock units convert into common stock on a one-for-one basis.
  • [F3]Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
  • [F4]As previously reported, on February 26, 2020, the reporting person received a grant of 44,965 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 26, 2021, resulting in the vesting and settlement of 14,988 shares of common stock. The second anniversary occurred on February 25, 2022 (the business day prior to February 26, 2022, which fell on a weekend), resulting in the vesting and settlement of 14,988 shares of common stock, as shown in Table I. The remaining 14,989 restricted stock units are shown in Table II, and are scheduled to vest on February 26, 2023.
  • [F5]As previously reported, on February 27, 2019, the reporting person received a grant of 27,130 time-based restricted stock units that vest in one-third increments on each of the first, second and third anniversaries of the date of grant. The first anniversary occurred on February 27, 2020, resulting in the vesting and settlement of 9,043 shares of common stock. The second anniversary occurred on February 26, 2021 (the business day prior to February 27, 2021, which fell on a weekend), resulting in the vesting and settlement of 9,043 shares of common stock. The third anniversary occurred on February 25, 2022 (the business day prior to February 27, 2022, which fell on a weekend), resulting in the vesting and settlement of 9,044 shares of common stock, as shown in Table I.
  • [F6]Time-based restricted stock units are settled in shares of the Company's common stock upon vesting.

Issuer

TENET HEALTHCARE CORP

CIK 0000070318

Entity typeother

Related Parties

1
  • filerCIK 0001396106

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:39 PM ET
Size
21.7 KB